Diagnostic value of plasma viscosity testing for patients with COVID-19.

Gleghorn, Daniel M; Olayiwola, Orisadare; Omer, Anisa; Lynn, Roderick; Norcliffe, David; Robinson, Mark

Gleghorn, Daniel M; Olayiwola, Orisadare; Omer, Anisa; Lynn, Roderick; Norcliffe, David; Robinson, Mark.

Gleghorn DM; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Olayiwola O; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Omer A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Lynn R; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Norcliffe D; Sherwood Forest Hospitals NHS Foundation Trust, Cambridge, UK.
Robinson M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Int J Lab Hematol ; 43(4): O227-O229, 2021 08.

Article in English | MEDLINE | ID: covidwho-1166002

Subject(s)

Blood Viscosity; COVID-19/blood; Plasma/chemistry; Adult; Aged; COVID-19/diagnosis; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; SARS-CoV-2/isolation & purification

Keywords

COVID-19; hyperinflammatory; plasma viscosity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma / Blood Viscosity / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Int J Lab Hematol Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: Ijlh.13532

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google